A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
Trial ID or NCT#
NCT00185562
Status
NOT RECRUITING
Purpose
A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy
Official Title
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
Eligibility Criteria
Ages Eligible for Study: Older than 45 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Age 45 or older, >/=2 tender and 2 swollen joints, inadequate response to NSAID therapy, hand radiographs with evidence of erosive changes, acceptable form of birth control
Exclusion Criteria:
- - Autoimmune arthropathy, History of psoriasis, Previous TNF therapy, current use of any DMARD, evidence of TB, history of Hep C, B, or HIV
Investigator(s)
View on ClinicalTrials.gov